Finally, patients with CRC who had recurrence had lower SFRP2 methylation levels than those without recurrence (p = 0.013) (Fig. 1E), with an AUC of 0.821 (95% CI 0.700–0.942) (Fig. 1H, Supplementary Table 1). Here, SFRP2 is linked to colorectal carcinoma.